Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, 1(81), p. e11-e11, 2019
DOI: 10.1136/annrheumdis-2019-216610
Links
Tools
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease
Journal article published in 2019 by
Corrado Campochiaro 
,
Giulio Cavalli,
Nicola Farina ,
Alessandro Tomelleri ,
Giacomo De Luca,
Lorenzo Dagna
,
Giulio Cavalli,
Nicola Farina ,
Alessandro Tomelleri ,
Giacomo De Luca,
Lorenzo Dagna
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 